Probenecid a edin a wɔde nim no wɔ dwa so ne Probalan no s yɛ aduro bi a ɛma adeɛ a yɛfrɛ no uric acid a ɛwɔ dwonsɔ mu no dɔɔso. Aduro yi dwuma titire pa ara ne sɛ ɛsa nyarewa a yɛfrɛ wɔn gout ne hyperuricemia.

Wɔyɛɛ Probenecid aduro no de hyɛɛ caronamide aduro no ananmu[1]

Ne Dwumadie wɔ Ayarehwɛ mu

sesa

Aduro yi dwuma titire pa ara ne sɛ ɛsa nyarewa a yɛfrɛ wɔn gout ne hyperuricemia. Ɛtɔ da a, wɔtumi de ma antibayɔtese (antibiotics ) a ɛwɔ aduro bi mu no yɛ kɛse. Ɛno boa ma wɔde sa berɛboɔ yareɛ .[2]

Wɔtumi nso de yɛ masking agent,[3]

Baabi a Menyaa Mmoa Firiiɛ

sesa
  1. Mason RM (June 1954). "Studies on the effect of probenecid (benemid) in gout". Annals of the Rheumatic Diseases. 13 (2): 120–130. doi:10.1136/ard.13.2.120. PMC 1030399. PMID 13171805.
  2. Cox VC, Zed PJ (March 2004). "Once-daily cefazolin and probenecid for skin and soft tissue infections". The Annals of Pharmacotherapy. 38 (3): 458–463. doi:10.1345/aph.1d251. PMID 14970368. S2CID 11449580.
  3. Morra V, Davit P, Capra P, Vincenti M, Di Stilo A, Botrè F (December 2006). "Fast gas chromatographic/mass spectrometric determination of diuretics and masking agents in human urine: Development and validation of a productive screening protocol for antidoping analysis". Journal of Chromatography A. 1135 (2): 219–229. doi:10.1016/j.chroma.2006.09.034. hdl:2318/40201. PMID 17027009. S2CID 20282106.